XML 57 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2017
Business Acquisition [Line Items]  
Business Acquisition, Pro Forma Information
Pro forma combined financial information 
The following unaudited pro forma combined financial information for the years ended December 31, 2017 and 2016, respectively, gives effect to the Vascular Solutions and NeoTract acquisitions as if they were completed at the beginning of the earliest period presented. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have occurred under the ownership and management of the Company.
 
2017
 
2016
 
(unaudited)
Net revenue
$
2,255,696

 
$
2,084,439

Net income
$
119,934

 
$
106,512

Basic earnings per common share:
 
 
 
Net income
$
2.66

 
$
2.46

Diluted earnings per common share:
 
 
 
Net income
$
2.57

 
$
2.24

Weighted average common shares outstanding:
 
 
 
Basic
45,004

 
43,325

Diluted
46,664

 
47,646

Vascular Solutions, Inc.  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table presents the purchase price allocation among the assets acquired and liabilities assumed with respect to the Vascular Solutions acquisition:
 
(Dollars in thousands)
Assets
 

Current assets
$
61,592

Property, plant and equipment
45,533

Intangible assets
539,250

Goodwill
524,872

Other assets
728

Total assets acquired
1,171,975

Less:
 

Current liabilities
15,079

Deferred tax liabilities
181,372

Liabilities assumed
196,451

Net assets acquired
$
975,524

Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination
The following table sets forth the components of identifiable intangible assets acquired and the ranges of the useful lives as of the date of the Vascular Solutions acquisition:
 
Fair value
 
Useful life range
 
(Dollars in thousands)
 
(Years)
Intellectual property
$
248,200

 
10- 20
In-process research and development ("IPR&D")
15,600

 
Indefinite
Trade names
16,650

 
20
Customer relationships
258,800

 
25
NeoTract, Inc  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table presents the purchase price allocation among the assets acquired and liabilities assumed with respect to the NeoTract acquisition:
 
(Dollars in thousands)
Assets
 

Current assets
$
32,887

Property, plant and equipment
6,980

Intangible assets
763,314

Goodwill
341,171

Other assets
184

Total assets acquired
1,144,536

Less:
 

Current liabilities
13,580

Deferred tax liabilities
155,806

Liabilities assumed
169,386

Net assets acquired
$
975,150

Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination
The following table sets forth the components of identifiable intangible assets acquired and the ranges of the useful lives as of the date of the NeoTract acquisition:
 
Fair value
 
Useful life
 
(Dollars in thousands)
 
(Years)
Intellectual property
$
492,118

 
15
Trade names
161,637

 
25
Customer relationships
109,559

 
15